GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:AVEO
Delisted

AVEO Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$15.00
+0 (+0%)
At Close: Apr 18, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $15.00 $15.00 Tuesday, 18th Apr 2023 AVEO stock ended at $15.00. During the day the stock fluctuated 0% from a day low at $15.00 to a day high of $15.00.
90 days $14.99 $15.00
52 weeks $3.41 $15.00

Historical AVEO Pharmaceuticals prices

Date Open High Low Close Volume
Nov 21, 2022 $14.82 $14.85 $14.82 $14.85 273 166
Nov 18, 2022 $14.83 $14.85 $14.83 $14.84 287 966
Nov 17, 2022 $14.84 $14.86 $14.81 $14.86 139 638
Nov 16, 2022 $14.86 $14.86 $14.82 $14.84 192 968
Nov 15, 2022 $14.78 $14.89 $14.75 $14.87 476 470
Nov 14, 2022 $14.79 $14.81 $14.76 $14.77 783 976
Nov 11, 2022 $14.80 $14.82 $14.79 $14.80 299 841
Nov 10, 2022 $14.80 $14.82 $14.77 $14.81 497 474
Nov 09, 2022 $14.78 $14.81 $14.76 $14.80 412 847
Nov 08, 2022 $14.78 $14.80 $14.74 $14.79 1 602 958
Nov 07, 2022 $14.77 $14.82 $14.76 $14.78 635 348
Nov 04, 2022 $14.80 $14.81 $14.76 $14.77 876 761
Nov 03, 2022 $14.77 $14.87 $14.71 $14.83 1 926 073
Nov 02, 2022 $14.77 $14.79 $14.76 $14.79 1 367 403
Nov 01, 2022 $14.78 $14.81 $14.76 $14.77 1 753 140
Oct 31, 2022 $14.77 $14.82 $14.75 $14.77 1 423 716
Oct 28, 2022 $14.77 $14.80 $14.77 $14.78 1 238 359
Oct 27, 2022 $14.77 $14.80 $14.77 $14.77 1 662 009
Oct 26, 2022 $14.76 $14.84 $14.76 $14.77 2 291 472
Oct 25, 2022 $14.75 $14.78 $14.75 $14.78 2 034 754
Oct 24, 2022 $14.74 $14.78 $14.74 $14.76 2 328 284
Oct 21, 2022 $14.74 $14.81 $14.74 $14.76 2 342 916
Oct 20, 2022 $14.70 $14.80 $14.67 $14.77 7 054 595
Oct 19, 2022 $14.77 $14.79 $14.69 $14.73 5 074 724
Oct 18, 2022 $14.73 $14.95 $14.64 $14.92 23 149 522
Click to get the best stock tips daily for free!

About AVEO Pharmaceuticals

AVEO Pharmaceuticals AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC, HCC, immunologically cold tumors, and CCA. The company has also completed a Phase II ... AVEO Profile

Golden Star

Ticker Date Change Price
FTSL Apr 18 0.130% $46.22
LNG Apr 17 2.33% $156.81
FCN Apr 16 1.98% $207.62
ELV Apr 16 4.98% $506.97
AKR Apr 05 5.38% $16.53
ITCI Apr 05 8.91% $68.44
SARK Mar 28 17.19% $26.88
ARCC Mar 25 2.68% $20.12
CCK Mar 20 2.77% $77.29
STT Mar 19 2.60% $72.62
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT